Biocon has reported results for its first quarter ended June 30, 2011
The company’s net profit for the quarter declined by 16.46% at Rs 60.40 crore as compared to Rs 72.30 crore for the quarter ended June 30, 2010. Its total Income from operation has increased by 5.33% to Rs 356.36 crore for the quarter under review from Rs 338.33 crore for the corresponding quarter of the previous year.
On Consolidated basis, the Group’s net profit has registered a fall of 7.81% at Rs 70.75 crore for the quarter ended June 30, 2011 as compared to Rs 76.74 crore for the quarter ended June 30, 2010. Its total Income from operation has increased by 10.90% to Rs 454.01 crore for the quarter from Rs 409.37 crore for the similar quarter of the previous year.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1470.05 |
Dr. Reddys Lab | 5938.25 |
Cipla | 1480.80 |
Zydus Lifesciences | 1037.80 |
Lupin | 1598.05 |
View more.. |